Enter assignee name

EPO Patents = 1

Trademarks = 7

Forward Citations = 42

Loading Chart...

7 inventors (with patents filed for the assignee):

Ziqing Qian (6 out of 14 patents)

Dehua Pei (5 out of 31 patents)

Natarajan Sethuraman (2 out of 2 patents)

4. Jason Ruth (2 out of 2 patents)

5. Lou A Tartaglia (1 out of 1 patent)

6. Louis A Tartaglia (1 out of 1 patent)

7. Kyle A Totaro (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. 12378267 - Synthesis of FMOC-protected morpholino monomers and oligomers (2025-08-05),

2. 11987821 - Compositions and methods for treating mitochondrial neurogastrointestinal encephalopathy (2024-05-21),

3. 11225506 - Cell penetrating peptides and methods of making and using thereof (2022-01-18),

4. 11168310 - Compositions and methods for treating mitochondrial neurogastrointestinal encephalopathy (2021-11-09),

5. 10815276 - Cell penetrating peptides and methods of making and using thereof (2020-10-27),

6. 10626147 - Cell penetrating peptides and methods of making and using thereof (2020-04-21),

Entrada Therapeutics is a biotechnology company dedicated to developing small molecule therapeutics for the treatment of devastating diseases. Their innovative technology platform enables the efficient delivery of drugs into cells to target previously undruggable diseases. With a focus on addressing unmet medical needs, Entrada is committed to advancing breakthrough therapies that can make a difference in patients' lives.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

6 Patents

#269 in Boston, MA

#2,473 in Massachusetts

#43,752 in US

Boston, MA, United States of America

Entrada Therapeutics, Inc.